111, Inc.

NASDAQ:YI

$0.8299 USD

-$0.09 (-9.77%)

Volume
330.88K
Average Volume
326.32K
Market Capitalization
$45.68M
P/E Ratio
-2.02
Dividend Yield
0.00%
Price Target
$
Year High
$1.97
Year Low
$0.55
Payout Ratio
$0.00
Current Ratio
$1.09

Industry, Sector & symbol

Stock Exchange NASDAQ Global Market
CEO Mr. Junling Liu
Industry Medical - Pharmaceuticals
Sector Healthcare
Current Symbol YI
CUSIP 68247Q102
CIK 0001738906
Web https://www.111.com.cn
Phone 86 21 2053 6666
Currency USD
Employees 1520
Country CN

Liquidity

Debt-to-Equity Ratio -0.27
Payout Ratio 0.00
Current Ratio 1.09
Quick Ratio 0.51
Cash Ratio 0.20

Sales & Book Value

Annual Sales $14.95B
Price / Sales 0.02
Cash Flow 1.22
Price / Cash Flow 3.16
Price / Book -0.82

Price Target and Rating

Average Stock Price Forecast $
High Stock Price Forecast $
Low Stock Price Forecast $
Forecast Upside/Downside %
Consensus Rating Sell
Rating Score(0-5) 2
Research Coverage 0 Analysts

Profitability

EPS (Most Recent Fiscal Year) $-4.66
Trailing P/E Ratio -2.02
PEG Ratio -0.09
P/E Growth -0.09
Net Income $-392.69M
Net Margin -1.74%
Pretax Margin -1.45%
Return on Equity 42.19%
Return on Assets -8.43%

Financials Score

AltmanZ Score 2.95
Piotroski Score 5.00
Working Capital 237.02M
Total Assets 3.03B
Ebit -191.76M
Market Cap 45.68M
Total Liabilities 2.72B

Poll Results

About 111, Inc. (NASDAQ:YI) Stock

111, Inc. operates an integrated online and offline platform in the healthcare market in the People's Republic of China. It operates through two segments, B2B and B2C. The company sells medical and wellness products through online retail, and wholesale and retail pharmacies, as well as provides value-added services that include online consultation services and electronic prescription services to consumers. It offers prescription and over-the counter drugs, including western and traditional Chinese medicines; nutritional supplements, such as vitamins and dietary products; contact lenses; medical supplies and devices comprising bandages and thermometers; and personal care products consisting of skin care, birth control, and sexual wellness products; and baby products. The company also operat ... es an online marketplace where third-party sellers can directly sell to pharmacies; provides online loan application services to the clients of 1 Pharmacy, which include pharmacies and wholesalers; and data and supply chain integration services. As of December 31, 2021, it operated 14 offline retail pharmacies under the Yi Hao Pharmacy brand name in Guangzhou, Tianjin, Kunshan, Chongqing, and Wuhan provinces. In addition, the company offers warehousing, logistics, procurement, research and development, and consulting services; and software development and information technology support services. It serves pharmacies, pharmaceutical companies and distributors, medical professionals, and insurance companies. The company was formerly known as New Peak Group and changed its name to 111, Inc. in April 2018. 111, Inc. was founded in 2010 and is headquartered in Shanghai, the People's Republic of China.

111, Inc. (YI) Q3 2024 Earnings Call Transcript

2024-11-27 12:56:05

111, Inc. (NASDAQ:YI ) Q3 2024 Results Conference Call November 27, 2024 7:30 AM ET Company Participants Dr. Gang Yu - Co-Founder and Executive Chairman Junling Liu - Co-Founder, Chairman and Chief Executive Officer Luke Chen - Chief Financial Officer Haihui Wang - Chief Operating Officer Conference Call Participants Jessie Lu - HSBC Robert Sassoon - Water Tower Research Operator Hello, everyone, and thank you for joining 111's Conference Call today. On the call today from the Company are Dr. Gang Yu, Co-Founder and Executive Chairman; Mr.

111, Inc. Announces Third Quarter 2024 Unaudited Financial Results

2024-11-27 01:00:00

Maintained Operational Profitability for the Third Consecutive Quarter Operating Expenses as a Percentage of Revenues Decreased 160 Basis Points YoY Held Positive Operating Cash Flow for Three Consecutive Quarters SHANGHAI , Nov. 27, 2024 /PRNewswire/ -- 111, Inc. ("111" or the "Company") (NASDAQ: YI), a leading tech-enabled healthcare platform company committed to reshaping the value chain of healthcare industry by digitally empowering the upstream and downstream in China, today announced its unaudited financial results for the third quarter ended September 30, 2024. Third Quarter 2024 Highlights Net revenues were RMB3.6 billion (US$513.1 million), remaining relatively flat compared to the same quarter last year.

111, Inc. to Participate in Fireside Chat with Water Tower Research on December 6, 2024

2024-11-21 05:00:00

SHANGHAI , Nov. 21, 2024 /PRNewswire/ -- 111, Inc. ("111" or the "Company") (NASDAQ: YI), a leading tech-enabled healthcare platform company committed to reshaping the value chain of healthcare industry by digitally empowering the upstream and downstream in China, today announced that it will participate in a fireside chat with Robert Sassoon, senior research analyst at Water Tower Research ("WTR") on Friday, December 6, 2024 at 11:00 a.m. ET. Mr. Junling Liu, Co-Founder, Chairman, and Chief Executive Officer of 111, will discuss the Company's Q3 2024 earnings (to be reported on Wednesday, November 27, 2024), along with challenges, opportunities, and the NASDAQ share price compliance issue.

111 Reschedules Third Quarter 2024 Unaudited Financial Results Announcement to November 27, 2024 - Conference Call to Follow

2024-11-04 06:00:00

SHANGHAI , Nov. 4, 2024 /PRNewswire/ -- 111, Inc. ("111" or the "Company") (NASDAQ: YI), a leading tech-enabled healthcare platform company committed to reshaping the value chain of healthcare industry by digitally empowering the upstream and downstream in China, today announced that its release of unaudited financial results for the third quarter ended September 30, 2024, previously scheduled for Thursday, November 28, 2024, will now occur before the U.S. market opens on Wednesday, November 27, 2024. 111's management team will host an earnings conference call at 7:30 AM U.S. Eastern Time on Wednesday, November 27, 2024 (8:30 PM Beijing Time on the same day).

111, Inc. Announces Change to Board of Directors

2024-11-04 05:00:00

SHANGHAI , Nov. 4, 2024 /PRNewswire/ -- 111, Inc. ("111" or the "Company") (NASDAQ: YI), a leading tech-enabled healthcare platform company committed to reshaping the value chain of healthcare industry by digitally empowering the upstream and downstream in China, today announced that Dr. Leon Lian Yong Chen has tendered his resignation from the position as the Company's director for personal reasons, effective on November 4, 2024. The board has also appointed Mr.

Frequently Asked Questions

What is the current 111, Inc. (YI) stock price?

111, Inc.(NASDAQ:YI) stock price is $0.8299 in the last trading session. During the trading session, YI stock reached the peak price of $1.97 while $0.55 was the lowest point it dropped to. The percentage change in YI stock occurred in the recent session was --9.77% while the dollar amount for the price change in YI stock was -$-0.09.

YI's industry and sector of operation?

The NASDAQ listed YI is part of Medical - Pharmaceuticals industry that operates in the broader Healthcare sector.

Who are the executives of YI?

Dr. Gang Yu Ph.D. | Co-Founder & Executive Chairman
Mr. Junling Liu | Co-Founder, Acting Chief Financial Officer, Chairman & Chief Executive Officer
Mr. Haihui Wang | Co-Chief Operating Officer
Mr. Pengcheng Zhu | Co-Chief Operating Officer
Monica Mu | IR Director

How many employees does YI have?

Number of YI employees currently stands at 1520. YI operates from No.295 ZuChongZhi Road, Shanghai, None 201203, CN.

Link for YI official website?

Official Website of YI is: https://www.111.com.cn

How do I contact YI?

YI could be contacted at phone #86 21 2053 6666 and can also be accessed through its website. YI operates from No.295 ZuChongZhi Road, Shanghai, None 201203, CN.

How many shares of YI are traded daily?

The average number of YI shares traded daily for last 3 months was 326.32K.

What is the market cap of YI currently?

The market value of YI currently stands at $45.68M with its latest stock price at $0.8299